SweetValueLab
Write for us

Charles River Laboratories International, Inc. — Financial Statements & Ratios

CRL
NYSEHealthcareMedical - Diagnostics & ResearchCIK 0001100682criver.comAbout CRL
Last close · Oct 16, 2026300.15−6.09 (−1.99%)
Market cap$14.5B

Key indicators

Revenue4.0BTTM−0.7% on a year earlier+8.5% a year, FY2018–FY2025
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
2.3B 2.6B+15.7%2.9B+11.5%3.5B+21.1%4.0B+12.3%4.1B+3.9%4.0B−1.9%4.0B−0.9%4.0B−0.7%3.9B 4.0B 4.3B
— 15.7% 11.5% 21.1% 12.3% 3.9% -1.9% -0.9% -0.7% -2.5% 2.5% 5.9%
$4.62 $5.07+9.7%$7.20+42.0%$7.60+5.6%$9.48+24.7%$9.22−2.7%$0.20−97.8%-$2.91−1555.0%-$4.80−272.1%$11.37 $12.82 $14.38
Profitability
14.6% 13.4%−1.2 pt14.8%+1.4 pt16.7%+1.9 pt16.4%−0.3 pt14.9%−1.4 pt5.6%−9.3 pt0.6%−5.0 pt2.3%−0.8 pt· · ·
10.0% 9.6%−0.4 pt12.5%+2.8 pt11.0%−1.4 pt12.2%+1.2 pt11.5%−0.7 pt0.5%−10.9 pt-3.6%−4.1 pt-6.0%−4.3 pt· · ·
17.2% 15.4%−1.8 pt17.2%+1.8 pt15.4%−1.8 pt16.3%+0.9 pt13.2%−3.1 pt0.6%−12.6 pt-4.6%−5.2 pt— · · ·
Cash
301.1M 340.4M+13.1%380.0M+11.6%532.0M+40.0%294.9M−44.6%365.4M+23.9%501.6M+37.3%518.5M+3.4%— · · ·
13.3% 13.0%−0.3 pt13.0%+0.0 pt15.0%+2.0 pt7.4%−7.6 pt8.8%+1.4 pt12.4%+3.5 pt12.9%+0.5 pt— · · ·
Balance sheet
1.26x 1.15x−0.10x0.93x−0.22x1.05x+0.12x0.91x−0.14x0.74x−0.17x0.65x−0.09x0.68x+0.03x0.92x+0.23x· · ·
49.02M 49.69M+1.4%50.61M+1.8%51.42M+1.6%51.30M−0.2%51.45M+0.3%51.63M+0.3%49.56M−4.0%48.02M−2.6%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jun 27, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.